The miRNA-29 family, on the other hand, may restore aberrant methylation in lung cancer by targeting the 3'-untranslated region of DNMT3A and DNMT3B, which are typically overexpressed in lung cancer and are associated with a poor prognosis. Here, DNMT3B is linked to lung cancer.